Asia Pacific Influenza Drug Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	220 Pages	Data Bridge Market Research	April, 2024	DAABD18813141

Best Price Guarantee
Price	from $3,500
Length	220 Pages
Publisher	Data Bridge Market Research
Published Date	April, 2024
SKU	DAABD18813141

Asia Pacific Influenza Drug Market

Asia-Pacific influenza drug market is expected to reach USD 2,538,320.36 thousand by 2031, from USD 1,661,384.77 thousand in 2023, growing at a CAGR of 5.7% in the forecast period of 2023 to 2031.
Market Segmentation:
Asia-Pacific Influenza Drug Market, By Type (Influenza A, Influenza B, and Influenza C), Treatment (Vaccine and Drugs), Route of Administration (Oral, Intramuscular, Intradermal, Intranasal, and Intravenous), Age (Pediatrics and Adults), End User (Hospitals, and Home Care), Distribution Channel (Direct Tenders and Retail Sales), Country (China, Japan, India, Australia, South Korea, Thailand, Singapore, Indonesia, Malaysia, Philippines, and Rest of Asia-Pacific)- Industry Trends & Forecast to 2031

Some of the major factors contributing to the growth of the Asia-Pacific influenza drug market are:

• Increasing prevalence rate of influenza
• Government initiatives and vaccination programs
• Advancements in medical research and technology

Market Players:

The key market players for Asia-Pacific influenza drug market are listed below:

• Ambu A/S
• GSK plc.
• Sanofi S.A.
• CSL,
• Astrazeneca Plc
• F. Hoffmann-La Roche Ltd
• Viatris Inc.,
• Abbott
• Amneal Pharmaceuticals LLC.
• AbbVie Inc
• BioCryst Pharmaceuticals Inc.
• Lupin
• Zydus Pharmaceuticals, Inc.
• Macleods Pharmaceuticals Ltd.
• Viatris Inc.
• DAIICHI SANKYO COMPANY
• LIMITED, Cipla Inc.
• Shionogi & Co., Ltd.
• Teva Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Limited
• NATCO Pharma Limited
• Alvogen

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Asia-pacific Influenza Drug Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 DBMR Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modelling; 2.7 Market Application Coverage Grid; 2.8 Product Lifeline Curve; 2.9 DBMR Market Position Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter's Five Forces Model
5 Market Overview: 5.1 Drivers; 5.1.1 Increasing Prevalence Rate Of Influenza; 5.1.2 Government Initiatives And Vaccination Programs; 5.1.3 Advancements In Medical Research And Technology; 5.1.4 Continous Launches Of The New Drugs And Vaccine; 5.2 Restraints; 5.2.1 Adverse Effect Of Anti-influenza Drugs; 5.2.2 Counterfeit Of Drug In Pharmaceutical Industry; 5.3 Opportunities; 5.3.1 Integration Of Telemedicine And Digital Health Solutions; 5.3.2 Development Of Combination Therapies; 5.3.3 Advancing Universal Vaccines; 5.4 Challenges; 5.4.1 Emergence Of Drug Resistant Strains; 5.4.2 Inefficiency In The Supply Chain Of Vaccine
6 Asia-pacific Influenza Drug Market, By Type: 6.1 Overview; 6.2 Influenza A; 6.3 Influenza B; 6.4 Influenza C
7 Asia-pacific Influenza Drug Market, By Treatment: 7.1 Overview; 7.2 Vaccines; 7.3 Drugs
8 Asia-pacific Influenza Drug Market, By Route Of Administration: 8.1 Overview; 8.2 Oral; 8.3 Intramuscular; 8.4 Intradermal; 8.5 Intranasal; 8.6 Intravenous
9 Asia-pacific Influenza Drug Market, By Age: 9.1 Overview; 9.2 Pediatrics; 9.3 Adults
10 Asia-pacific Influenza Drug Market, By End User: 10.1 Overview; 10.2 Hospitals; 10.3 Homecare
11 Asia-pacific Influenza Drug Market, By Distribution Channel: 11.1 Overview; 11.2 Direct Tender; 11.3 Retail Sales
12 Asia-pacific Influenza Drug Market, By Country: 12.1 Asia-pacific; 12.1.1 Japan; 12.1.2 China; 12.1.3 South Korea; 12.1.4 India; 12.1.5 Australia; 12.1.6 Malaysia; 12.1.7 Thailand; 12.1.8 Indonesia; 12.1.9 Singapore; 12.1.10 Philippines; 12.1.11 Rest Of Asia-pacific
13 Asia-pacific Influenza Drug Market: Company Landscape: 13.1 Company Share Analysis: Asia-pacific
14 Swot Analysis
15 Company Profiles: 15.1 Gsk Plc.; 15.1.1 Company Snapshot; 15.1.2 Revenue Analysis; 15.1.3 Company Share Analysis; 15.1.4 Product Portfolio; 15.1.5 Recent Developments; 15.2 Sanofi; 15.2.1 Company Snapshot; 15.2.2 Revenue Analysis; 15.2.3 Company Share Analysis; 15.2.4 Product Portfolio; 15.2.5 Recent Developments; 15.3 Csl; 15.3.1 Company Snapshot; 15.3.2 Revenue Analysis; 15.3.3 Company Share Analysis; 15.3.4 Product Portfolio; 15.3.5 Recent Developments; 15.4 Astrazeneca; 15.4.1 Company Snapshot; 15.4.2 Revenue Analysis; 15.4.3 Company Share Analysis; 15.4.4 Product Portfolio; 15.4.5 Recent Development; 15.5 F. Hoffmann-la Roche Ltd.; 15.5.1 Company Snapshot; 15.5.1 Revenue Analysis; 15.5.2 Company Share Analysis; 15.5.3 Product Portfolio; 15.5.4 Recent Development; 15.6 Abbott; 15.6.1 Company Snapshot; 15.6.2 Revenue Analysis; 15.6.3 Product Portfolio; 15.6.4 Recent Development; 15.7 Abbvie Inc.; 15.7.1 Company Snapshot; 15.7.2 Revenue Analysis; 15.7.3 Product Portfolio; 15.7.4 Recent Development; 15.8 Alvogen; 15.8.1 Company Snapshot; 15.8.2 Product Portfolio; 15.8.3 Recent Development; 15.9 Amneal Pharmaceuticals Llc.; 15.9.1 Company Snapshot; 15.9.2 Revenue Analysis; 15.9.3 Product Portfolio; 15.9.4 Recent Development; 15.10 Biocryst Pharmaceuticals, Inc.; 15.10.1 Company Snapshot; 15.10.2 Revenue Analysis; 15.10.3 Product Portfolio; 15.10.4 Recent Development; 15.11 Cipla Inc.; 15.11.1 Company Snapshot; 15.11.2 Revenue Analysis; 15.11.3 Product Portfolio; 15.11.4 Recent Development; 15.12 Daiichi Sankyo Company, Limited; 15.12.1 Company Snapshot; 15.12.2 Revenue Analysis; 15.12.3 Product Portfolio; 15.12.4 Recent Development; 15.13 Lupin; 15.13.1 Company Snapshot; 15.13.2 Revenue Analysis; 15.13.3 Product Portfolio; 15.13.4 Recent Development; 15.14 Macleods Pharmaceuticals Ltd.; 15.14.1 Company Snapshot; 15.14.2 Product Portfolio; 15.14.3 Recent Development; 15.15 Natco Pharma Limited; 15.15.1 Company Snapshot; 15.15.2 Revenue Analysis; 15.15.3 Product Portfolio; 15.15.4 Recent Development; 15.16 Shionogi & Co., Ltd.; 15.16.1 Company Snapshot; 15.16.2 Revenue Analysis; 15.16.3 Product Portfolio; 15.16.4 Recent Development; 15.17 Takeda Pharmaceutical Company Limited; 15.17.1 Company Snapshot; 15.17.2 Revenue Analysis; 15.17.3 Product Portfolio; 15.17.4 Recent Development; 15.18 Teva Pharmaceutical Industries Ltd.; 15.18.1 Company Snapshot; 15.18.2 Revenue Analysis; 15.18.3 Product Portfolio; 15.18.4 Recent Development; 15.19 Viatris Inc.; 15.19.1 Company Snapshot; 15.19.2 Revenue Analysis; 15.19.3 Product Portfolio; 15.19.4 Recent Development; 15.20 Zydus Pharmaceuticals, Inc.; 15.20.1 Company Snapshot; 15.20.2 Revenue Analysis; 15.20.3 Product Portfolio; 15.20.4 Recent Developments
16 Questionnaire
17 Related Reports: Table 1 Asia-pacific Influenza Drug Market, By Type, 2022-2031 (Usd Thousand); Table 2 Asia-pacific Influenza A In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand); Table 3 Asia-pacific Influenza B In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand); Table 4 Asia-pacific Influenza C In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand); Table 5 Asia-pacific Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 6 Asia-pacific Influenza A In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand); Table 7 Asia-pacific Drugs In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand); Table 8 Asia-pacific Vaccines In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 9 Asia-pacific Quadrivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 10 Asia-pacific Trivalentin Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 11 Asia-pacific Bivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 12 Asia-pacific Monovalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 13 Asia-pacific Vaccines In Influenza Drug Market, By Technology, 2022-2031 (Usd Thousand); Table 14 Asia-pacific Inactivated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 15 Asia-pacific Live Attenuated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 16 Asia-pacific Drugs In Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 17 Asia-pacific Influenza Drug Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 18 Asia-pacific Oral Market, By Region, 2022-2031 (Usd Thousand); Table 19 Asia-pacific Intramuscular In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand); Table 20 Asia-pacific Intradermal In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand); Table 21 Asia-pacific Intranasal In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand); Table 22 Asia-pacific Intravenous In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand); Table 23 Asia-pacific Influenza Drug Market, By Age, 2022-2031 (Usd Thousand); Table 24 Asia-pacific Pediatrics Market, By Region, 2022-2031 (Usd Thousand); Table 25 Asia-pacific Adults In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand); Table 26 Asia-pacific Influenza Drug Market, By End User, 2022-2031 (Usd Thousand); Table 27 Asia-pacific Hospitals In Asia-pacific Influenza Drug Market, By Region, 2022-2031 (Usd Thousand); Table 28 Asia-pacific Homecare In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand); Table 29 Asia-pacific Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 30 Asia-pacific Direct Tender In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand); Table 31 Asia-pacific Retail Sales In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand); Table 32 Asia-pacific Retail Sales In Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 33 Asia-pacific Influenza Drug Market, By Country, 2022-2031 (Usd Thousand); Table 34 Asia-pacific Influenza Drug Market, By Type, 2022-2031 (Usd Thousand); Table 35 Asia-pacific Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 36 Asia-pacific Vaccines In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 37 Asia-pacific Quadrivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 38 Asia-pacific Trivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 39 Asia-pacific Bivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 40 Asia-pacific Monovalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 41 Asia-pacific Vaccines In Influenza Drug Market, By Technology, 2022-2031 (Usd Thousand); Table 42 Asia-pacific Inactivated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 43 Asia-pacific Live Attenuated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 44 Asia-pacific Drugs In Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 45 Asia-pacific Influenza Drug Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 46 Asia-pacific Influenza Drug Market, By Age, 2022-2031 (Usd Thousand); Table 47 Asia-pacific Influenza Drug Market, By End User, 2022-2031 (Usd Thousand); Table 48 Asia-pacific Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 49 Asia-pacific Retail Sales In Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 50 Japan Influenza Drug Market, By Type, 2022-2031 (Usd Thousand); Table 51 Japan Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 52 Japan Vaccines In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 53 Japan Quadrivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 54 Japan Trivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 55 Japan Bivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 56 Japan Monovalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 57 Japan Vaccines In Influenza Drug Market, By Technology, 2022-2031 (Usd Thousand); Table 58 Japan Inactivated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 59 Japan Live Attenuated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 60 Japan Drugs In Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 61 Japan Influenza Drug Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 62 Japan Influenza Drug Market, By Age, 2022-2031 (Usd Thousand); Table 63 Japan Influenza Drug Market, By End User, 2022-2031 (Usd Thousand); Table 64 Japan Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 65 Japan Retail Sales In Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 66 China Influenza Drug Market, By Type, 2022-2031 (Usd Thousand); Table 67 China Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 68 China Vaccines In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 69 China Quadrivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 70 China Trivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 71 China Bivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 72 China Monovalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 73 China Vaccines In Influenza Drug Market, By Technology, 2022-2031 (Usd Thousand); Table 74 China Inactivated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 75 China Live Attenuated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 76 China Drugs In Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 77 China Influenza Drug Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 78 China Influenza Drug Market, By Age, 2022-2031 (Usd Thousand); Table 79 China Influenza Drug Market, By End User, 2022-2031 (Usd Thousand); Table 80 China Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 81 China Retail Sales In Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 82 South Korea Influenza Drug Market, By Type, 2022-2031 (Usd Thousand); Table 83 South Korea Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 84 South Korea Vaccines In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 85 South Korea Quadrivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 86 South Korea Trivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 87 South Korea Bivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 88 South Korea Monovalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 89 South Korea Vaccines In Influenza Drug Market, By Technology, 2022-2031 (Usd Thousand); Table 90 South Korea Inactivated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 91 South Korea Live Attenuated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 92 South Korea Drugs In Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 93 South Korea Influenza Drug Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 94 South Korea Influenza Drug Market, By Age, 2022-2031 (Usd Thousand); Table 95 South Korea Influenza Drug Market, By End User, 2022-2031 (Usd Thousand); Table 96 South Korea Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 97 South Korea Retail Sales In Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 98 India Influenza Drug Market, By Type, 2022-2031 (Usd Thousand); Table 99 India Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 100 India Vaccines In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 101 India Quadrivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 102 India Trivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 103 India Bivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 104 India Monovalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 105 India Vaccines In Influenza Drug Market, By Technology, 2022-2031 (Usd Thousand); Table 106 India Inactivated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 107 India Live Attenuated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 108 India Drugs In Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 109 India Influenza Drug Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 110 India Influenza Drug Market, By Age, 2022-2031 (Usd Thousand); Table 111 India Influenza Drug Market, By End User, 2022-2031 (Usd Thousand); Table 112 India Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 113 India Retail Sales In Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 114 Australia Influenza Drug Market, By Type, 2022-2031 (Usd Thousand); Table 115 Australia Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 116 Australia Vaccines In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 117 Australia Quadrivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 118 Australia Trivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 119 Australia Bivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 120 Australia Monovalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 121 Australia Vaccines In Influenza Drug Market, By Technology, 2022-2031 (Usd Thousand); Table 122 Australia Inactivated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 123 Australia Live Attenuated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 124 Australia Drugs In Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 125 Australia Influenza Drug Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 126 Australia Influenza Drug Market, By Age, 2022-2031 (Usd Thousand); Table 127 Australia Influenza Drug Market, By End User, 2022-2031 (Usd Thousand); Table 128 Australia Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 129 Australia Retail Sales In Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 130 Malaysia Influenza Drug Market, By Type, 2022-2031 (Usd Thousand); Table 131 Malaysia Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 132 Malaysia Vaccines In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 133 Malaysia Quadrivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 134 Malaysia Trivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 135 Malaysia Bivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 136 Malaysia Monovalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Table 137 Malaysia Vaccines In Influenza Drug Market, By Technology, 2022-2031 (Usd Thousand); Table 138 Malaysia Inactivated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 139 Malaysia Live Attenuated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 140 Malaysia Drugs In Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 141 Malaysia Influenza Drug Market, By Route Of Administration, 2022-2031 (Usd Thousand); Table 142 Malaysia Influenza Drug Market, By Age, 2022-2031 (Usd Thousand); Table 143 Malaysia Influenza Drug Market, By End User, 2022-2031 (Usd Thousand); Table 144 Malaysia Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 145 Malaysia Retail Sales In Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand); Table 146 Thailand Influenza Drug Market, By Type, 2022-2031 (Usd Thousand); Table 147 Thailand Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand); Table 148 Thailand Vaccines In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand); Table 149 Thailand Quadrivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand); Figure 1 Asia-pacific Influenza Drug Market: Segmentation; Figure 2 Asia-pacific Influenza Drug Market: Data Triangulation; Figure 3 Asia-pacific Influenza Drug Market: Droc Analysis; Figure 4 Asia-pacific Influenza Drug Market: Asia-pacific Vs Regional Market Analysis; Figure 5 Asia-pacific Influenza Drug Market: Company Research Analysis; Figure 6 Asia-pacific Influenza Drug Market: Interview Demographics; Figure 7 Asia-pacific Influenza Drug Market: Market Application Coverage Grid; Figure 8 Asia-pacific Influenza Drug Market: DBMR Market Position Grid; Figure 9 Asia-pacific Influenza Drug Market: Vendor Share Analysis; Figure 10 Asia-pacific Influenza Drug Market: Segmentation; Figure 11 Government Initiatives And Vaccination Programs Is Driving The Growth Of The Asia-pacific Influenza Drug Market From 2024 To 2031; Figure 12 The Influenza A Segment Is Expected To Account For The Largest Share Of The Asia-pacific Influenza Drug Market In 2024 And 2031; Figure 13 Drivers, Restraints, Opportunities And Challenges Of Asia-pacific Influenza Drugs Market; Figure 14 Asia-pacific Influenza Drug Market: By Type, 2023; Figure 15 Asia-pacific Influenza Drug Market: By Type, 2024-2031 (Usd Thousand); Figure 16 Asia-pacific Influenza Drug Market: By Type, Cagr (2024-2031); Figure 17 Asia-pacific Influenza Drug Market: By Type, Lifeline Curve; Figure 18 Asia-pacific Influenza Drug Market: By Treatment, 2023; Figure 19 Asia-pacific Influenza Drug Market: By Treatment, 2024-2031 (Usd Thousand); Figure 20 Asia-pacific Influenza Drug Market: By Cagr (2024-2031); Figure 21 Asia-pacific Influenza Drug Market: By Treatment, Lifeline Curve; Figure 22 Asia-pacific Influenza Drug Market : By Route Of Administration, 2023; Figure 23 Asia-pacific Influenza Drug Market : By Route Of Administration, 2024-2031 (Usd Thousand); Figure 24 Asia-pacific Influenza Drug Market : By Route Of Administration, Cagr (2024-2031); Figure 25 Asia-pacific Influenza Drug Market : By Route Of Administration, Lifeline Curve; Figure 26 Asia-pacific Influenza Drug Market : By Age, 2023; Figure 27 Asia-pacific Influenza Drug Market : By Age, 2024-2031 (Usd Thousand); Figure 28 Asia-pacific Influenza Drug Market : By Age, Cagr (2024-2031); Figure 29 Asia-pacific Influenza Drug Market : By Age, Lifeline Curve; Figure 30 Asia-pacific Influenza Drug Market : By End User, 2023; Figure 31 Asia-pacific Influenza Drug Market : By End User, 2024-2031 (Usd Thousand); Figure 32 Asia-pacific Influenza Drug Market : By End User, Cagr (2024-2031); Figure 33 Asia-pacific Influenza Drug Market : By End User, Lifeline Curve; Figure 34 Asia-pacific Influenza Drug Market: By Distribution Channel, 2024-2031 (Usd Thousand); Figure 35 Asia-pacific Influenza Drug Market: By Distribution Channel, 2023; Figure 36 Asia-pacific Influenza Drug Market: By Distribution Channel, Cagr (2024-2031); Figure 37 Asia-pacific Influenza Drug Market: By Distribution Channel, Lifeline Curve; Figure 38 Asia-pacific Influenza Drug Market: Snapshot (2023); Figure 39 Asia-pacific Influenza Drug Market: Company Share 2023 (%)